

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Potassium Channel ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tolbutamide | ✔ | 98% | |||||||||||||||||
| Glimepiride |
++++
SUR2B, IC50: 7.3 nM SUR1, IC50: 5.4 nM |
97% | |||||||||||||||||
| Dronedarone HCl | ✔ | 95% | |||||||||||||||||
| Gliquidone |
++
Potassium channel, IC50: 27.2 nM |
99% | |||||||||||||||||
| TRAM-34 |
+++
IKCa1 (KCa3.1), Kd: 20 nM |
98% | |||||||||||||||||
| Glibenclamide | ✔ | 98% | |||||||||||||||||
| Amiodarone HCl | ✔ | 97% | |||||||||||||||||
| Gliclazide |
++
Potassium channel, IC50: 184 nM |
98% | |||||||||||||||||
| Repaglinide | ✔ | 98% | |||||||||||||||||
| Dofetilide | ✔ | 98% | |||||||||||||||||
| Nateglinide | ✔ | 99% | |||||||||||||||||
| Quinine HCl dihydrate | ✔ | 98% | |||||||||||||||||
| ML133 HCl |
+
Kir2.1, IC50: 290 nM |
99% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | ICA-27243 is a selective, potent and orally active KCNQ2/Q3 potassium channel opener with an EC50 value of 0.38 μM. ICA-27243 is less effective in activating KCNQ4 and KCNQ3/Q5. ICA-27243 exhibits antiepileptic and anticonvulsant effects[1][2]. In SH-SY5Y human neuroblastoma cells, ICA-27243 produces membrane potential hyperpolarisation, which is prevented in combination with the M-current inhibitors XE-991 and Linopirdine. In CHO cells stably expressing heterotrimeric KCNQ2/Q3 channels, ICA-27243 enhanced 86Rb+ efflux (EC50=0.2 μM) and whole-cell currents (EC50=0.4 μM). Activation of KCNQ2/Q3 channels was associated with a voltage-dependent hyperpolarising shift in channel activation (V1/2 shifted to -19 mV at 10 μM)[1]. |
| Concentration | Treated Time | Description | References | |
| dorsal root ganglion neurons | 10 µM | 8 days | To evaluate the effect of ICA-27243 on axonal growth of dorsal root ganglion neurons, results showed that ICA-27243 tended to decrease axonal elongation. | Int J Mol Sci. 2024 Jul 3;25(13):7327 |
| dorsal root ganglion neurons | 10 µM | 4 days | To evaluate the effect of ICA-27243 on axonal growth of dorsal root ganglion neurons, results showed that ICA-27243 tended to decrease axonal elongation. | Int J Mol Sci. 2024 Jul 3;25(13):7327 |
| F11 cells | 3 μM | 7–8 min | ICA-27243 inhibited CAP-induced [Ca2+]i increases, with effects similar to RTG | Int J Mol Sci. 2019 Sep 4;20(18):4322 |
| F11 cells | 1–20 μM | 7–8 min | ICA-27243 dose-dependently inhibited BK-induced [Ca2+]i increases, with a maximal inhibition of ~60% and an IC50 of ~5 μM | Int J Mol Sci. 2019 Sep 4;20(18):4322 |
| Cryopreserved dorsal root ganglion neurons | 10 μM | 10 seconds | To test the hyperpolarization effect of ICA-27243 on cryopreserved dorsal root ganglion neurons, results showed cryopreservation did not affect the hyperpolarization effect of ICA-27243. | Mol Pain. 2018 Jan-Dec;14:1744806917749669 |
| Dorsal root ganglion neurons (Wistar rats) | 10 μM | 10 seconds | To test the hyperpolarization effect of ICA-27243 on dorsal root ganglion neurons from Wistar rats, results showed a weaker hyperpolarization effect of ICA-27243. | Mol Pain. 2018 Jan-Dec;14:1744806917749669 |
| Dorsal root ganglion neurons (SD rats) | 10 μM | 10 seconds | To test the hyperpolarization effect of ICA-27243 on dorsal root ganglion neurons from SD rats, results showed ICA-27243 significantly hyperpolarized the neuronal membrane potential. | Mol Pain. 2018 Jan-Dec;14:1744806917749669 |
| spinal cord organotypic cultures (SCOCs) | 10 μM | 30 min | prevented MN degeneration under acute excitotoxic conditions | Neurotherapeutics. 2024 Mar;21(2):e00319 |
| Administration | Dosage | Frequency | Description | References | ||
| Transgenic SOD1G93A mice | ALS transgenic mouse model | Intraperitoneal injection | 10 mg/kg/day | Daily administration until the end of the experiment | Improved neuromuscular function, maintained motor coordination, reduced spinal motor neuron death and glial reactivity | Neurotherapeutics. 2024 Mar;21(2):e00319 |
| Rats | Spontaneously hypertensive rats (SHR) and normotensive rats (WKY) | Intravenous injection | 11.2 µmol/kg | Single dose, observed for 15 minutes | ICA-27243 increased tyramine-stimulated norepinephrine overflow and epinephrine secretion in female SHR and reduced the TPR-response to tyramine in female SHR. | Front Physiol. 2018 Feb 20;9:117 |
| Animal study | Administered orally at doses of 1-100 mg/kg, ICA-27243 exhibits anticonvulsant activity in a mouse model of maximal electroshock epilepsy with an ED50 value of 8.4 mg/kg[1]. |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.72mL 0.74mL 0.37mL |
18.61mL 3.72mL 1.86mL |
37.22mL 7.44mL 3.72mL |
|
| CAS号 | 325457-89-4 |
| 分子式 | C12H7ClF2N2O |
| 分子量 | 268.65 |
| SMILES Code | O=C(NC1=CC=C(Cl)N=C1)C2=CC=C(F)C(F)=C2 |
| MDL No. | MFCD17166959 |
| 别名 | |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 250 mg/mL(930.59 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1